Daegu, South Korea

Wookyung Yu


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wookyung YU: Innovator in Thermal Sensitivity of DNA Glycosylase

Introduction

Wookyung YU is a notable inventor based in Daegu, South Korea, recognized for his significant contributions to the field of biotechnology. With a strong emphasis on improving molecular biology techniques, he has developed innovative solutions that enhance the efficiency of PCR (Polymerase Chain Reaction) procedures.

Latest Patents

Wookyung YU holds a patent for a "Mutant Uracil DNA glycosylase with improved thermal sensitivity." This invention presents a mutant UDG that demonstrates enhanced thermal sensitivity compared to wild-type UDG. The mutant UDG is particularly advantageous, as it does not inhibit PCR reactions, making it ideally suited for the development of PCR/qPCR Premix and diagnostic kits that require lower temperatures during melting and amplification processes.

Career Highlights

Throughout his career, YU has worked with prominent organizations such as Enzynomics Co. Ltd. and the Daegu Gyeongbuk Institute of Science and Technology. His roles in these institutions have significantly contributed to his expertise in enzymatic applications and biotechnological advancements.

Collaborations

Wookyung YU has collaborated with several talented colleagues, including Yong Keol Shin and Jeongyeon YOON. These partnerships have likely fostered an environment of innovative thinking and have facilitated the development of cutting-edge biotechnological solutions.

Conclusion

Wookyung YU's innovative work in developing a mutant UDG showcases his commitment to advancing molecular biology techniques. His contributions, particularly in improving thermal sensitivity for PCR applications, highlight the importance of innovation in biotechnology. As he continues to collaborate with skilled professionals in the field, the potential for further advancements remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…